gyki 53655 has been researched along with fluorobenzenes in 1 studies
Studies (gyki 53655) | Trials (gyki 53655) | Recent Studies (post-2010) (gyki 53655) | Studies (fluorobenzenes) | Trials (fluorobenzenes) | Recent Studies (post-2010) (fluorobenzenes) |
---|---|---|---|---|---|
111 | 0 | 22 | 3,032 | 581 | 1,214 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ciprian-Ollivier, J; Perret, L; Sebban, C; Spedding, M; Tesolin-Decros, B | 1 |
1 other study(ies) available for gyki 53655 and fluorobenzenes
Article | Year |
---|---|
Effects of phencyclidine (PCP) and MK 801 on the EEGq in the prefrontal cortex of conscious rats; antagonism by clozapine, and antagonists of AMPA-, alpha(1)- and 5-HT(2A)-receptors.
Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Carbonic Anhydrase Inhibitors; Clozapine; Consciousness; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Interactions; Electroencephalography; Fluorobenzenes; Hallucinogens; Male; Models, Biological; Phencyclidine; Piperidines; Prazosin; Prefrontal Cortex; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, AMPA; Receptors, Serotonin; Serotonin Antagonists | 2002 |